African Americans less likely than whites to get colonoscopy despite family history of colon cancer

African Americans who have multiple first-degree relatives with colon cancer are less likely than whites with affected relatives to undergo recommended screening procedures, according to a report in the March 24 issue of Archives of Internal Medicine.

Family history increases risk for colon cancer, especially if multiple first-degree relatives develop the condition or if one immediate family member is diagnosed before age 60, according to background information in the article. Most clinical guidelines recommend that individuals with these family history factors begin undergoing screening for colorectal cancer at age 40 years, as opposed to age 50 for the general population. A colonoscopy every five years is the screening method of choice.

Harvey J. Murff, M.D., M.P.H., of Vanderbilt University, Nashville, Tenn., and colleagues analyzed screening behavior in 41,830 individuals (32,265 African Americans and 9,565 whites) age 40 to 79 years. Demographic characteristics, family cancer history, tobacco and alcohol use, medical history, physical activity level and medication use were assessed at initial interviews, conducted between 2002 and 2006. Participants were also asked whether they had undergone sigmoidoscopy or colonoscopy for colon cancer screening.

A total of 538 African Americans (1.7 percent) reported either multiple first-degree relatives with colon cancer or a first-degree relative diagnosed before age 50, compared with 255 whites (2.7 percent). Of those, 27.3 percent of African Americans and 43.1 percent of whites reported having a colonoscopy within the past five years, as recommended. Also in this group, African Americans were less likely than whites (19.7 percent vs. 46.9 percent) to report a personal diagnosis of colorectal polyps, precursors to colorectal cancer.

“For both African Americans and whites with family histories of colon cancer, the most common reason given for not having had a colonoscopy or flexible sigmoidoscopy was the lack of a recommendation from their health care provider, and this reason was more commonly reported by African Americans,” the authors write.

Source: JAMA and Archives Journals

Related stories:

Patients unaware of link between smoking and bladder cancer
Even though cigarette smoking accounts for up to half of all bladder cancer cases, few people are aware of the connection – including more than three-quarters of patients who have bladder cancer, according to a new study from the University of Michigan Comprehensive Cancer Center.
Family history and screening for colorectal cancer
A new study indicates that African Americans with a family history of colorectal cancer are less likely to be screened than African Americans at average risk for the disease. There is also some evidence to indicate that AA with a family history are less likely to be screened than their white counterparts. The study is published in the July 15, 2008 issue of Cancer, a peer-reviewed journal of the American Cancer Society.
US cancer deaths down but far too few Americans screened for colon cancer
New data revealing decreasing trends in cancer deaths in the United States overall, and in colorectal cancer deaths in particular, highlight the remarkable benefits of colorectal cancer screening tests, but the lifesaving potential of these tests is unrealized for many Americans according to experts from the American College of Gastroenterology. Racial minorities, uninsured Americans and even Medicare patients who should be tested are not being screening appropriately, and other recent studies reveal that they are diagnosed with more advanced cancers compared to patients with private insurance.
Breast cancer gene mutation more common in Hispanic, young black women, study finds
A genetic mutation already known to be more common in Ashkenazi Jewish breast cancer patients is also prevalent in Hispanic and young African-American women with breast cancer, according to one of the largest, multiracial studies of the mutation to date.
Whites take supplemental breast cancer therapy more often than blacks
A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.
Survival differences by race most apparent in advanced stages of breast cancer
Racial differences in breast cancer survival increase according to stage of disease, a new study finds. Published in the September 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, a retrospective analysis of survival data demonstrates that within each stage, African American women had larger tumors and were more likely to have disease that had spread to nearby lymph nodes.
Study notes decline in male births in the US and Japan
A study published in this week’s online edition of Environmental Health Perspectives reports that during the past thirty years, the number of male births has decreased each year in the U.S. and Japan.
Cancer researchers call for ethnicity to be taken into account
Breast cancer research needs to investigate how a person's ethnicity influences their response to treatment and its outcome, according to a new Comment piece in today's Lancet (18 July) by researchers from Imperial College London.

News discussion:

Medicine & Health news